Zhengyun Zou

CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients

Shu Su, Bian Hu, Jie Shao et al. · Scientific Reports · 2016 · 299 citations · Full text

Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors

Fangjun Chen, Zhengyun Zou, Juan Du et al. · Journal of Clinical Investigation · 2019 · 217 citations · Full text

PSGR, a novel prostate-specific gene with homology to a G protein-coupled receptor, is overexpressed in prostate cancer.

Lixia Xu, B G Stackhouse, Kelly Farina da Silva Florence et al. · PubMed · 2000 · 203 citations

Pathology, Tumor Biology, Genitourinary Cancer +16

iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancer

Naiqing Ding, Zhengyun Zou, Huizi Sha et al. · Nature Communications · 2019 · 123 citations · Full text

No Genome-Wide Protein Sequence Convergence for Echolocation

Zhengyun Zou, J. Zhang · Molecular Biology and Evolution · 2015 · 115 citations · Full text

Genetics, Genomics, Sequence Convergence +16